TORONTO, Jan. 26, 2012 /PRNewswire via COMTEX/ —
EMO Capital (nuvi:OTCBB), a publicly
traded American company listed on the OTCBB is pleased to announce that
is has commenced the process of seeking a listing on London’s Plus
Stock Exchange and the launch of its new website in the United Kingdom.

The growth of the European marketplace is an integral component of
NUVitality’s business plan. The inter-listing of the Company on the
Plus Stock Exchange will allow European investors a platform to invest
into the Company. In addition, the launch of a new website dedicated
to European e-commerce and multi-channel retailers seeking Internet
sales opportunities in Europe will further enhance the Company’s
revenue stream. This two prong approach into the European market will
expand the geographic reach of not only the company’s customers but
also, new retailers and shareholders as well.

Nuvitality, focuses on the diet and wellness industry; a market in the
UK that alone stands at 63 million people , $1.6 Billion in sales
annually and currently has the highest obesity rates in all of Europe.*

According to a new healthcare market research report Global Weight Loss
and Gain Market (2009 – 2014)’, published by Markets and Markets (
www.marketsandmarkets.com ), the total global weight loss market is expected to be worth US$586.3
billion by 2014. The market has a compound annual growth rate (CAGR) of
10.9% from 2009 to 2014. NuVitality global focus remains on target to
seek a global platform of distributors and clients to take advantage of
the growing product line up of the Company’s diet and wellness
products.

Emo Capital Corp thru its wholly owned subsidiary NuVitality Labs is an
international direct marketing corporation specializing in health and
wellness categories.
www.emocapitalcorp.com

Statements in this press release may be “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of
1995. Words such as “anticipate,” “believe,” “estimate,” “expect,”
“intend”, “dramatically” and similar expressions, as they relate to the
company or its management, identify forward-looking statements. These
statements are based on current expectations, estimates and projections
about the company’s business based, in part, on assumptions made by
management. These statements are not guarantees of future performance
and involve risks, uncertainties and assumptions that are difficult to
predict. Therefore, actual outcomes and results may, and probably will,
differ materially from what is expressed or forecasted in such
forward-looking statements due to numerous factors, including those
described above and those risks discussed from time to time in Emo
Capital’s filings with the Securities and Exchange Commission. In
addition, such statements could be affected by risks and uncertainties
related to the ability of the company to control product demand, market
and customer acceptance, competition, pricing and development
difficulties, as well as general industry and market conditions and
growth rates and general economic conditions. Any forward-looking
statements speak only as of the date on which they are made, and the
company does not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this
release. Information on Emo Capitals’s website does not constitute a
part of this release.

*
http://www.candis.co.uk/magazine/familyhealthnews/family-health-june-2011

http://www.marketsandmarkets.com/PressReleases/global-market-for-weight-loss-worth- $726-billion-by-2014.asp

SOURCE Emo Capital

Copyright (C) 2012 PR Newswire. All rights reserved